# Efficacy and Safety of Lenalidomide Combined With Azacitidine vs Azacitidine in the Treatment of MDS-RS

> **NCT06004765** · PHASE4 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 138 (estimated)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DRUG:** Lenalidomide
- **DRUG:** Azacitidine

## Key facts

- **NCT ID:** NCT06004765
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08
- **Primary completion:** 2024-08
- **Final completion:** 2025-08
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06004765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06004765, "Efficacy and Safety of Lenalidomide Combined With Azacitidine vs Azacitidine in the Treatment of MDS-RS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06004765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*